title: Placing HPS2-THRIVE in context using Bayesian analysis.
authors.affiliation: McGill University Health Center, Montreal, Quebec, Canada. Electronic address: christopher.labos@mail.mcgill.ca.
authors.forename: Christopher
authors.initials: C
authors.lastname: Labos
authors.affiliation: McGill University Health Center, Montreal, Quebec, Canada.
authors.forename: James M
authors.initials: JM
authors.lastname: Brophy
authors.affiliation: McGill University Health Center, Montreal, Quebec, Canada.
authors.forename: George
authors.initials: G
authors.lastname: Thanassoulis
mesh_terms: D001499:Bayes Theorem; D002318:Cardiovascular Diseases / Q000150:complications / Q000401:mortality*; D003692:Delayed-Action Preparations; D050171:Dyslipidemias / Q000150:complications / Q000188:drug therapy*; D005483:Flushing / Q000139:chemically induced / Q000517:prevention & control; D006801:Humans; D007211:Indoles / Q000008:administration & dosage / Q000009:adverse effects; D057847:Lipid Regulating Agents / Q000008:administration & dosage / Q000009:adverse effects; D009525:Niacin / Q000008:administration & dosage / Q000009:adverse effects; D015230:Prostaglandin D2 / Q000037:antagonists & inhibitors; D018570:Risk Assessment / Q000379:methods
chemical_list: D003692:Delayed-Action Preparations; D007211:Indoles; D057847:Lipid Regulating Agents; C518174:MK-0524; D009525:Niacin; D015230:Prostaglandin D2
keywords: Bayesian; Cholesterol; Niacin; Outcomes